ASGCT's vision is to serve as a catalyst to transform medicine by
advancing gene and cell therapies to benefit patients and society.
Not exact matches
His research has spanned hematopoiesis,
gene therapy, stem
cell biology, genomics
and cancer, consistently focusing on bringing the very latest research
advances to patients with heretofore incurable diseases.
These include the ability to bring new, innovative products to the market; progress in oncology, such as the approval of Genentech's drug Avastin for breast cancer
and advances in the use of
gene therapy, despite some setbacks; continuing progress in research on stem
cells; the emergence of treatments for previously untreated diseases;
and solutions for food
and fuel shortages, such as biocrops
and biofuels.
For his part, Collins, who has led NIH since 2009
and been kept on by the Trump administration, pointed to an array of promising NIH activities, including the development of new technologies to provide insights into human brain circuitry
and function through the Brain Research through
Advancing Innovative Neuroethologies (BRAIN initiative)
and the use of the
gene - editing tool CRISPR - Cas9 to correct mutations
and clear the way to develop
and test a «curative
therapy» for the first molecular disease: sickle
cell disease.
The technical
advances emerging from
gene therapy have fueled the larger fields of
cell and immune
therapy, where DNA, immune molecules,
and viruses are all elements to be manipulated, in concert or one at a time.
So for 17 patients with
advanced melanoma who didn't have tumor - fighting T
cells and had failed existing treatments, Rosenberg's team tried
gene therapy.
He was awarded a European Research Council
Advanced Investigator Grant (ERC) in 2009, the Outstanding Achievement Award from the American Society of
Gene and Cell Therapy (ASGCT) in 2014
and from ESGCT in 2015, an Honorary doctorate from the Vrije University, Brussel, in 2015, the Jimenez Diaz Prize in 2016,
and the Beutler Prize from the American Society of Hematology (ASH) in 2017.
His work also contributed to
advance the use of artificial nucleases for targeted genome editing in
cell and gene therapy.
Data from this trial was previously presented at World
Advanced Therapies and Regenerative Medicine (May 17 - 19,2017; London, UK)
and the 20th Annual Meeting American Society of
Gene and Cell Therapy (ASGCT, May 10 - 13, 2017; DC, USA).
StemFit
cell culture media has been independently evaluated by CGT Catapult, an independent centre of excellence helping
advance the UK
cell and gene therapy industry.
He is Professor of
Cell and Gene Therapy in the Advanced Centre for Biochemical Engineering, University College London working on the clinical translation and commercialization of cell and gene therap
Cell and Gene Therapy in the Advanced Centre for Biochemical Engineering, University College London working on the clinical translation and commercialization of cell and gene therap
Gene Therapy in the
Advanced Centre for Biochemical Engineering, University College London working on the clinical translation
and commercialization of
cell and gene therap
cell and gene therap
gene therapies.
The only plausible methods of repairing stochastic nuclear DNA damage look to be the aforementioned
advanced molecular nanotechnology, something that lies some decades in the future, or major
advances in
gene therapy, to the point at which it could be cost - effective
and safe to scan
and conditionally alter the majority of
genes in the majority of
cells all at once.
Gene and cell therapies have made important medical
advances over the past three decade, developing technologies
and testing novel
therapies in multiple human clinical trials of many diseases.
Important reports from the Weiner lab include the first DNA vaccine studied for HIV as well as for cancer immune
therapy of cutaneous T
cell lymphoma, the early development of DNA encoded genetic adjuvants, including IL - 12,
advances in
gene optimization,
and advances in electroporation technologies resulting in improved
gene delivery.
University of Pennsylvania immunotherapy researcher Dr. Carl June, who led the development of an experimental
therapy for advanced childhood leukemia that is expected to become the first CAR T - cell therapy to win U.S. Food and Drug Administration approval, will give the keynote talk today at the Conference on Cell & Gene Therapy for HIV Cure at Fred Hutchinson Cancer Research
therapy for
advanced childhood leukemia that is expected to become the first CAR T -
cell therapy to win U.S. Food and Drug Administration approval, will give the keynote talk today at the Conference on Cell & Gene Therapy for HIV Cure at Fred Hutchinson Cancer Research Cen
cell therapy to win U.S. Food and Drug Administration approval, will give the keynote talk today at the Conference on Cell & Gene Therapy for HIV Cure at Fred Hutchinson Cancer Research
therapy to win U.S. Food
and Drug Administration approval, will give the keynote talk today at the Conference on
Cell & Gene Therapy for HIV Cure at Fred Hutchinson Cancer Research Cen
Cell &
Gene Therapy for HIV Cure at Fred Hutchinson Cancer Research
Therapy for HIV Cure at Fred Hutchinson Cancer Research Center.
We made history in August 2017 when the FDA approved a personalized
cell therapy for
advanced leukemia, the first - ever for cancer
cell and gene therapy.
Clinical
and Regenerative medicine refers to development
and implementation of
advanced therapeutic approaches that may involve the support of expertise in
gene /
cell therapy, tissue engineering, pharmacology
and pharmacogenomics, development of novel molecular target
therapy.